Latest news
Loading news…
Tularik
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). San Francisco, California, United States Founded 1991 251-500 employees For Profit
Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression.
Tularik was acquired by Amgen in 2004 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- TLRK
- Exchange
- NASDAQ
- IPO date
- Dec 10, 1999
- Raised at IPO
- $97M
- Delisted
- Aug 13, 2004
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
Company Info
- Founded
- 1991
- Employees
- 251-500
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 2
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Dec 10, 1999
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.4
- Trend (90d)
- -0.5
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Tularik
Loading news…
FAQs about Tularik
People who checked this page also checked these
Browse the full Acquirezy directory.